WHO Annex 2 Good Manufacturing Practices for Pharmaceutical Products, 1/14

WHO Annex 2 Good Manufacturing Practices for Pharmaceutical Products, 1/14

£0.00

2014 WHO Committee on Specifications for Pharmaceutical Preparations update to Annex 2, Good Manufacturing Practices for Pharmaceutical Products: Main Principles.

Description

WHO Annex 2 Good Manufacturing Practices for Pharmaceutical Products, 1/14

The WHO Expert Committee on Specifications for Pharmaceutical Preparations published an update to Annex 2, Good Manufacturing Practices for Pharmaceutical Products: Main Principles in 2014. This document contains the collective views of an international group of experts including representatives from international regulatory agencies, EU, IFPMA, IGPA, IPEC, PIC/S, UNICEF, BSP and USP.

  • Section 4, Qualification and Validation, outlines the expectations for pharma manufacturing validation programs, including validation of computers
  • Section 8.2, Self-Inspection, contains the requirement to self-inspect validation and re-validation programs
  • Section 14.13, Material Labeling, provides labeling exceptions when fully validated computerized systems are in use
  • Section 15.9, Documentation, lists requirements for electronic data and records management
  • Section 15.25, Batch Processing Records, and 15.28, Batch Packaging Records, contain recommendations to use validated computer programs
  • Section 15.28, Batch Processing Records, outlines information that needs to be associated with a signature or electronic password
  • Section 17, Good Practices in Quality Control, specifies responsibilities of the Quality Function, including roles in qualification and validation
Issuing Body WHO

 

Reviews

There are no reviews yet.

Be the first to review “WHO Annex 2 Good Manufacturing Practices for Pharmaceutical Products, 1/14”

Your email address will not be published.